Buchumschlag

Targeting cancer stem cells with defined compounds and drugs

Cancer stem cells (CSCs) are a subpopulation of tumor cells that possess self-renewal and tumor initiation capacity and the ability to give rise to the heterogenous lineages of cancer cells that comprise the tumor. CSCs possess numerous intrinsic mechanisms of resistance to chemotherapeutic drugs, n...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Naujokat, Cord (VerfasserIn) , Laufer, Stefan (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 14-02-2013
In: Journal of Cancer Research Updates
Year: 2013, Jahrgang: 2, Heft: 1, Pages: 36-67
ISSN:1929-2279
DOI:10.6000/1929-2279.2013.02.01.7
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.6000/1929-2279.2013.02.01.7
Verlag, lizenzpflichtig, Volltext: https://neoplasiaresearch.com/pms/index.php/jcru/article/view/401
Volltext
Verfasserangaben:Cord Naujokat and Stefan Laufer

MARC

LEADER 00000caa a2200000 c 4500
001 1778358497
003 DE-627
005 20240415193204.0
007 cr uuu---uuuuu
008 211123s2013 xx |||||o 00| ||eng c
024 7 |a 10.6000/1929-2279.2013.02.01.7  |2 doi 
035 |a (DE-627)1778358497 
035 |a (DE-599)KXP1778358497 
035 |a (OCoLC)1341430848 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Naujokat, Cord  |d 1964-  |e VerfasserIn  |0 (DE-588)123190592  |0 (DE-627)082401616  |0 (DE-576)184229537  |4 aut 
245 1 0 |a Targeting cancer stem cells with defined compounds and drugs  |c Cord Naujokat and Stefan Laufer 
264 1 |c 14-02-2013 
300 |a 32 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 24.11.2021 
520 |a Cancer stem cells (CSCs) are a subpopulation of tumor cells that possess self-renewal and tumor initiation capacity and the ability to give rise to the heterogenous lineages of cancer cells that comprise the tumor. CSCs possess numerous intrinsic mechanisms of resistance to chemotherapeutic drugs, novel tumor-targeted drugs and radiation therapy, allowing them to survive current cancer therapies and to initiate tumor recurrence and metastasis. Recently, different pathways that confer resistance and survival of CSCs, but also compounds and drugs that selectively target some of these pathways in CSCs have been identified. Such compounds and drugs include antibiotics like salinomycin, phytochemicals such as parthenolide, cyclopamine, EGCG, resveratrol, curcumin, sulforaphane and oxymatrine, the small molecule inhibitors vismodegib and repertaxin, monoclonal antibodies and antibody constructs raised against cell surface proteins expressed by CSCs, and, surprisingly, some classical drugs such as metformin, tranilast and thioridazine. These agents exhibit significant anti-CSC activity, alone or in combination with cytostatic drugs or tumor-targeted drugs, as recently shown in vitro and in human xenograft mice. Since current cancer therapies fail to eliminate CSCs, leading to cancer recurrence and progression, selective targeting of CSCs with compounds and drugs introduced herein may represent a novel therapeutic strategy to eradicate cancer. 
650 4 |a Cancer stem cells (CSCs) 
650 4 |a combination therapy. 
650 4 |a novel drugs 
650 4 |a novel therapeutics 
650 4 |a targeted therapy 
700 1 |a Laufer, Stefan  |d 1959-  |e VerfasserIn  |0 (DE-588)143984624  |0 (DE-627)704665662  |0 (DE-576)169215083  |4 aut 
773 0 8 |i Enthalten in  |t Journal of Cancer Research Updates  |d Mississauga : Lifescience Global, 2012  |g 2(2013), 1, Seite 36-67  |h Online-Ressource  |w (DE-627)81849221X  |w (DE-600)2810590-4  |w (DE-576)426495942  |x 1929-2279  |7 nnas  |a Targeting cancer stem cells with defined compounds and drugs 
773 1 8 |g volume:2  |g year:2013  |g number:1  |g pages:36-67  |g extent:32  |a Targeting cancer stem cells with defined compounds and drugs 
856 4 0 |u https://doi.org/10.6000/1929-2279.2013.02.01.7  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://neoplasiaresearch.com/pms/index.php/jcru/article/view/401  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20211123 
993 |a Article 
994 |a 2013 
998 |g 123190592  |a Naujokat, Cord  |m 123190592:Naujokat, Cord  |d 50000  |e 50000PN123190592  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1778358497  |e 4005041558 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 24.11.2021"],"language":["eng"],"recId":"1778358497","title":[{"title_sort":"Targeting cancer stem cells with defined compounds and drugs","title":"Targeting cancer stem cells with defined compounds and drugs"}],"person":[{"given":"Cord","family":"Naujokat","role":"aut","display":"Naujokat, Cord","roleDisplay":"VerfasserIn"},{"family":"Laufer","given":"Stefan","roleDisplay":"VerfasserIn","display":"Laufer, Stefan","role":"aut"}],"physDesc":[{"extent":"32 S."}],"relHost":[{"id":{"issn":["1929-2279"],"zdb":["2810590-4"],"eki":["81849221X"]},"origin":[{"publisherPlace":"Mississauga","dateIssuedDisp":"2012-","publisher":"Lifescience Global","dateIssuedKey":"2012"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Journal of Cancer Research Updates","title_sort":"Journal of Cancer Research Updates"}],"recId":"81849221X","language":["eng"],"note":["Gesehen am 28.09.22"],"disp":"Targeting cancer stem cells with defined compounds and drugsJournal of Cancer Research Updates","type":{"bibl":"periodical","media":"Online-Ressource"},"titleAlt":[{"title":"J. Can. Res. Updates"}],"part":{"volume":"2","text":"2(2013), 1, Seite 36-67","extent":"32","year":"2013","pages":"36-67","issue":"1"},"pubHistory":["1.2012 -"]}],"origin":[{"dateIssuedKey":"2013","dateIssuedDisp":"14-02-2013"}],"id":{"doi":["10.6000/1929-2279.2013.02.01.7"],"eki":["1778358497"]},"name":{"displayForm":["Cord Naujokat and Stefan Laufer"]}} 
SRT |a NAUJOKATCOTARGETINGC1402 

Ähnliche Einträge